Find similiar products:
The text only version may be available in large print, Braille or audio CD. For further information call emc accessibility on 0800 198 5000. The product code(s) for this leaflet is: PL20011/0020.
TARGAXAN 550 mg film-coated tablets
TARGAXAN® 550 mg film-coated tablets
rifaximin
1. What Targaxan is and what it is used for
2. What you need to know before you take Targaxan
3. How to take Targaxan
4. Possible side effects
5. How to store Targaxan
6. Contents of the pack and other information
Targaxan contains the active substance rifaximin. Targaxan is an antibiotic that destroys bacteria, which can cause a disease called hepatic encephalopathy (symptoms include agitation, confusion, muscle problems, difficulty in speaking and in some cases coma).
Targaxan is used in adults with liver disease to reduce the recurrence of episodes of overt hepatic encephalopathy.
Targaxan can either be used alone or more commonly together with medicines containing lactulose (a laxative).
Do not take Targaxan:
Talk to your doctor or pharmacist before taking Targaxan.
While you are taking Targaxan your urine may turn a reddish colour. This is quite normal.
Treatment with any antibiotic including rifaximin may cause severe diarrhoea. This can happen several months after you have finished taking the medicine. If you have severe diarrhoea during or after using Targaxan you should stop taking Targaxan and contact your doctor immediately.
If your liver problems are severe your doctor will need to observe you carefully.
This medicine contains less than 1 mmol sodium (23 mg) per tablet, that is to say essentially ‘sodium-free’.
Targaxan is not recommended for children and adolescents aged under 18 years. This medicine has not been studied in children and adolescents.
Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines.
Please tell your doctor if you are taking any of the following medicines:
If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before taking any medicine.
It is not known if Targaxan can harm your unborn baby. Targaxan is therefore not to be used if you are pregnant.
It is not known if rifaximin may be passed to your baby in breast milk. Targaxan is therefore not to be used if you are breast-feeding.
Targaxan does not normally affect the ability to drive and use machines, but may cause dizziness in some patients. If you feel dizzy you should not drive or operate machinery.
Always take this medicine exactly as your doctor has told you. Check with your doctor or pharmacist if you are not sure.
The recommended dose is 1 tablet twice a day taken with a glass of water.
Continue taking Targaxan until your doctor tells you to stop.
If you take more than the recommended number of tablets, even if you do not notice any problems, please contact your doctor.
Take the next dose at its normal time. Do not take a double dose to make up for a forgotten tablet.
Do not stop taking Targaxan without talking to your doctor first because your symptoms may return.
If you have any further questions on the use of this medicine, ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
Uncommon (may affect up to 1 in 100 people):
Not known (frequency cannot be estimated from the available data):
Common (may affect up to 1 in 10 people):
Uncommon (may affect up to 1 in 100 people):
Rare (may affect up to 1 in 1,000 people):
Not known (frequency cannot be estimated from the available data):
If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via Yellow Card Scheme Website: www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store.
By reporting side effects you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the carton and the blister after EXP. The expiry date refers to the last day of that month.
Targaxan does not require any special storage conditions.
Do not throw away any medicine via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help to protect the environment.
The active substance is rifaximin. Each tablet contains 550 mg rifaximin.
The other ingredients are:
Pink oval curved film-coated tablets marked with “RX” on one side.
Targaxan is available in cartons of 14, 28, 42, 56 and 98 tablets.
Not all pack-sizes may be marketed.
Or
This leaflet was last revised in 03/2021
This medicinal product is authorised in the Member States of the EEA under the following names:
TARGAXAN®: Belgium, Finland, Ireland, Luxembourg, United Kingdom
XIFAXAN®: Denmark, Germany, Netherlands, Norway, Sweden.
Other sources of information
If you need the information on this leaflet in an alternative format, such as large print, or Braille please ring 0800 198 5000.